<code id='600396002E'></code><style id='600396002E'></style>
    • <acronym id='600396002E'></acronym>
      <center id='600396002E'><center id='600396002E'><tfoot id='600396002E'></tfoot></center><abbr id='600396002E'><dir id='600396002E'><tfoot id='600396002E'></tfoot><noframes id='600396002E'>

    • <optgroup id='600396002E'><strike id='600396002E'><sup id='600396002E'></sup></strike><code id='600396002E'></code></optgroup>
        1. <b id='600396002E'><label id='600396002E'><select id='600396002E'><dt id='600396002E'><span id='600396002E'></span></dt></select></label></b><u id='600396002E'></u>
          <i id='600396002E'><strike id='600396002E'><tt id='600396002E'><pre id='600396002E'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:43
          Rachel Haurwitz of Caribou Biosciences
          Rachel Haurwitz, CEO of Caribou Biosciences. Elizabeth D. Herman for STAT

          Caribou Biosciences said Thursday that its off-the-shelf CAR-T therapy induced durable, complete remissions in patients with advanced B-cell lymphoma that move it closer to the benchmarks set by more established, patient-specific CAR-T therapies.

          In an update to an early-stage study, 44% of the 16 patients treated with Caribou’s on-demand therapy, called CB-010, achieved a complete remission lasting a minimum of six months — a key threshold of durability.

          advertisement

          The CB-010 result is still preliminary, but it begins to compare favorably to currently approved CAR-T therapies, which must be custom made for each patient and have shown durable remission rates in the range of 36-40%, said Caribou CEO Rachel Haurwitz.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          New company forms to vet health AI models, root out weaknesses
          New company forms to vet health AI models, root out weaknesses

          AdobeThemarketforartificialintelligenceinhealthcareisaboutastransparentasabrickwall.Newtoolsachievei

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          Parkland mass shooting to be reenacted for lawsuit

          0:49The"1200building"atMarjoryStonemanDouglasHighSchool,thecrimescenewherethe2018shootingstookplace,